We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TELO market cap is 125.6M. The company's latest EPS is USD -0.5555 and P/E is -7.45.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.08M | -1.92M | -1.47M | -5.95M | -2.91M |
| Net Income | -9.33M | -6.26M | -1.45M | -5.93M | -2.9M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -138k | -854k | -3.94M | -12.24M |
| Net Income | -138k | -854k | -13.07M | -16.53M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 4.77M | 3.5M | 2.1M | 1.04M | 1.32M |
| Total Liabilities | 1.34M | 486k | 534k | 600k | 681k |
| Total Equity | 3.44M | 3.02M | 1.57M | 442k | 643k |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 0 | 49k | 4.77M | 1.32M |
| Total Liabilities | 138k | 986k | 1.34M | 681k |
| Total Equity | -138k | -937k | 3.44M | 643k |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -3.86M | -1.94M | -3.46M | -4.46M | -5.07M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 3.86M | 5.21M | 5.35M | 5.3M | 6.34M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -119k | -469k | -3.86M | -5.07M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 119k | 470k | 3.86M | 6.34M |
| Market Cap | 125.6M |
| Price to Earnings Ratio | -7.45 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 97.41 |
| Price to Book Ratio | 191.63 |
| Dividend Yield | - |
| Shares Outstanding | 29.76M |
| Average Volume (1 week) | 164.02k |
| Average Volume (1 Month) | 134.4k |
| 52 Week Change | -50.64% |
| 52 Week High | 9.39 |
| 52 Week Low | 3.11 |
| Spread (Intraday) | 0.05 (1.17%) |
| Company Name | Telomir Pharmaceuticals Inc |
| Address |
900 west platt street, suite 200 tampa, florida 33606 |
| Website | https://www.telomirpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
